BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BD MAX¿ ENTERIC PARASITE PANEL

    MDR report key: 24415534 · Received February 23, 2026

    Report

    Report Number
    3007420875-2026-00022
    Event Type
    Malfunction
    Date Received
    February 23, 2026
    Date of Event
    May 24, 2025
    Report Date
    April 8, 2026
    Manufacturer
    GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
    Product Code
    OOI
    UDI-DI
    00382904429607
    PMA / PMN Number
    K220193
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    UK
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH CORRECTED INFORMATION: B.5. DESCRIBE EVENT OR PROBLEM: IT WAS REPORTED THAT DURING USE OF BD MAX¿ ENTERIC PARASITE PANEL, A FALSE POSITIVE CRYPTOSPORIDIUM AND GIARDIA PATIENT RESULT WAS OBTAINED. SAMPLE WAS SENT TO A REFERENCE LABORATORY AND WAS NEGATIVE. SAMPLE WAS ALSO TESTED WITH QUICKCHEK ASSAY AND WAS ALSO NEGATIVE. THERE WAS NO REPORT OF PATIENT IMPACT. B.3. DATE OF EVENT: 05/24/2025, D.4. MEDICAL DEVICE LOT: 4353345 , D.4. MEDICAL DEVICE EXPIRATION DATE: 07/25/2026, D.4 . MEDICAL DEVICE GTIN/UDI: (B)(4), H.4. DEVICE MANUFACTURE DATE: 01/21/2025. INVESTIGATION SUMMARY: THE COMPLAINT INVESTIGATION FOR DISCREPANT RESULTS WHEN USING THE BD MAX ENTERIC PARASITE PANEL ASSAY (REF (B)(4)) LOTS 4325885, 4353345, 5021178, 5097003, AND 5058301 WAS PERFORMED BY THE REVIEW OF MANUFACTURING RECORDS CUSTOMERS DATA ANALYSIS AND VERIFICATION OF COMPLAINTS HISTORY. THE REVIEW OF QUALITY CONTROL RECORDS OF BD MAX ENTERIC PARASITE PANEL LOTS 4325885, 4353345, 5021178, 5097003, AND 5058301 REVEALED NO ANOMALIES THAT COULD EXPLAIN THE CUSTOMERS FALSE POSITIVE RESULTS. THE CUSTOMER REPORTED MULTIPLE SAMPLES WHICH TESTED POSITIVE FOR CRYPTOSPORIDIUM WITH OR WITHOUT GIARDIA LAMBLIA ON THE BD MAX ENTERIC PARASITE PANEL (REF (B)(4)) FOR LOTS 4325885, 4353345, 5021178, 5097003, AND 5058301 DURING ROUTINE USE AND THESE RESULTS WERE NOT CONFIRMED WHEN EVALUATED BY ALTERNATIVE METHODS. THE CUSTOMER PROVIDED RUN FILES, PDF, AND CSV FORMATS FROM INSTRUMENTS (B)(6) FOR INVESTIGATION. MANUAL PCR CURVE ADJUDICATION FOR ALL NINE SAMPLES SUSPECTED FALSE POSITIVE RESULTS REVEALED STEP DISLOCATIONS IN EIGHT SAMPLES IN THE RAW PCR SIGNAL FOR THE CRYPTO TARGET ROX CHANNEL REACHING THE THRESHOLDS TO BE CONSIDERED A POSITIVE RESULT. STEP DISLOCATIONS SIMILAR TO THOSE OBSERVED FOR THE GIARDIA LAMBLIA FAM CHANNEL WERE ALSO OBSERVED FOR THE ENTAMOEBA HISTOLYTICA VIC CHANNEL TARGET, HOWEVER THE SIGNAL DID NOT CROSS THE POSITIVITY THRESHOLD FOR E HISTOLYTICA, AND ONLY INTERMITTENTLY EXCEEDED THE POSITIVE THRESHOLD FOR GIARDIA IN THREE SAMPLES. THIS ANALYSIS SUGGESTS THAT THE POSITIVE RESULTS FOR THE CRYPTO AND GIARDIA TARGETS ARE NOT LINKED TO TRUE AMPLIFICATION. IN CONTRAST THE SPC TARGET CY55 CHANNEL DEMONSTRATED TRUE AMPLIFICATION CHARACTERIZED BY EXPECTED SIGMOID AMPLIFICATION CURVES WITHOUT OBSERVABLE ANOMALIES. IT SHOULD BE NOTED THAT MANUAL CURVE ADJUDICATION HAS LIMITATIONS VISUAL EXAMINATION OF PCR CURVES FOR LOW SIGNAL OR ABERRANT CURVE GEOMETRY IS A CONSERVATIVE ASSESSMENT OF THE DATA. SINCE THE CURVES DO NOT SUGGEST TRUE AMPLIFICATION, IT IS LIKELY THAT THESE SAMPLES ARE, IN FACT, NEGATIVE WHICH IS ACCORDING TO CUSTOMER THE RESULT OBTAINED UPON ALTERNATIVE TESTING. BECAUSE THE EVENTS OCCURRED ON DIFFERENT BD MAX INSTRUMENTS DECKS AND PUMPS AND THAT THE EVENTS WERE OBSERVED ONLY EIGHT TIMES ACROSS FIVE BD MAX ENTERIC PARASITE PANEL LOTS OVER A SEVEN MONTH TIME PERIOD A LOT SPECIFIC ISSUE IS NOT SUSPECTED. THE ISSUE MAY BE ATTRIBUTABLE TO INTERFERING SUBSTANCES ORIGINATING FROM THE SAMPLES OR THEIR PREPARATION, BUT OVERALL THE CAUSE REMAINS UNKNOWN. THE NINTH SAMPLE POSITION A08 OF RUN 2737 APPEARS TO BE A SAMPLE AT THE ASSAY LIMIT OF DETECTION SHOWING TRUE AMPLIFICATION WITH A LATE CYCLE THRESHOLD. AS WITH ALL PCR BASED IN VITRO DIAGNOSTIC TESTS EXTREMELY LOW LEVELS OF TARGET BELOW THE ANALYTICAL SENSITIVITY OF THE ASSAY MAY BE DETECTED BUT RESULTS MAY NOT BE REPRODUCIBLE. THE LIMIT OF DETECTION VARIES BETWEEN TESTING METHODS. ALSO, A POSITIVE RESULT DOES NOT NECESSARILY INDICATE THE PRESENCE OF VIABLE ORGANISMS. IT DOES HOWEVER INDICATE THE PRESENCE OF ASSAY TARGET DNA. THERE IS NO INDICATION OF A REAGENT ISSUE BASED ON THE ANALYSIS OF THE COMPLAINTS RECEIVED FOR DISCREPANT RESULTS ON BD MAX ENTERIC PARASITE PANEL ASSAY LOTS 4325885, 4353345, 5021178, 5097003 AND 5058301. THE ROOT CAUSE WAS NOT IDENTIFIED. BD CANNOT CONFIRM THE COMPLAINT BASED ON THE INVESTIGATION THAT WAS PERFORMED. BD DID NOT INITIATE A CORRECTIVE AND PREVENTIVE ACTION CAPA SINCE NO TREND WAS IDENTIFIED.

    Additional Manufacturer Narrative · 0

    D.2. ADDITIONAL MEDICAL DEVICE TYPE: PCH. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT DURING USE OF BD MAX¿ ENTERIC PARASITE PANEL, A FALSE POSITIVE CRYPTOSPORIDIUM AND GIARDIA PATIENT RESULT WAS OBTAINED. SAMPLE WAS SENT TO A REFERENCE LABORATORY AND WAS NEGATIVE. SAMPLE WAS ALSO TESTED WITH QUICKCHEK ASSAY AND WAS ALSO NEGATIVE. THERE WAS NO REPORT OF PATIENT IMPACT.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT DURING USE OF BD MAX¿ ENTERIC PARASITE PANEL, A FALSE POSITIVE CRYPTOSPORIDIUM PATIENT RESULT WAS OBTAINED. SAMPLE WAS SENT TO A REFERENCE LABORATORY AND WAS CRYPTOSPORIDIUM NEGATIVE. SAMPLE WAS ALSO TESTED WITH QUICKCHEK ASSAY AND WAS ALSO CRYPTOSPORIDIUM NEGATIVE. THERE WAS NO REPORT OF PATIENT IMPACT.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    544937 BD MAX¿ ENTERIC PARASITE PANEL GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM OOI GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) 4353345 00382904429607

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Unknown